| __timestamp | Dynavax Technologies Corporation | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 84580000 | 19586000 |
| Thursday, January 1, 2015 | 86943000 | 29135000 |
| Friday, January 1, 2016 | 84493000 | 42791000 |
| Sunday, January 1, 2017 | 64988000 | 49577000 |
| Monday, January 1, 2018 | 74951000 | 89209000 |
| Tuesday, January 1, 2019 | 62331000 | 69099000 |
| Wednesday, January 1, 2020 | 28607000 | 75961000 |
| Friday, January 1, 2021 | 32228000 | 90467000 |
| Saturday, January 1, 2022 | 46600000 | 74552000 |
| Sunday, January 1, 2023 | 54886000 | 91593000 |
Infusing magic into the data realm
In the competitive landscape of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Supernus Pharmaceuticals, Inc. and Dynavax Technologies Corporation have demonstrated contrasting R&D investment strategies.
From 2014 to 2023, Supernus Pharmaceuticals has shown a remarkable upward trend, increasing its R&D expenses by approximately 368%, peaking in 2023. This consistent growth underscores their dedication to advancing pharmaceutical solutions. In contrast, Dynavax Technologies experienced a more volatile R&D spending pattern, with a significant dip in 2020, where expenses dropped by nearly 66% compared to 2014. However, they have since rebounded, showing a 92% increase by 2023.
These trends highlight the dynamic nature of R&D investments in the biotech sector, reflecting each company's strategic priorities and market positioning.
Research and Development: Comparing Key Metrics for AbbVie Inc. and Dynavax Technologies Corporation
Vertex Pharmaceuticals Incorporated or Dynavax Technologies Corporation: Who Invests More in Innovation?
R&D Insights: How Zoetis Inc. and Supernus Pharmaceuticals, Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Teva Pharmaceutical Industries Limited and Dynavax Technologies Corporation
R&D Insights: How Incyte Corporation and Dynavax Technologies Corporation Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Insmed Incorporated and Supernus Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Lantheus Holdings, Inc. vs Supernus Pharmaceuticals, Inc.
Alkermes plc vs Supernus Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: Alpine Immune Sciences, Inc. and Supernus Pharmaceuticals, Inc.
R&D Insights: How Amneal Pharmaceuticals, Inc. and Dynavax Technologies Corporation Allocate Funds
Analyzing R&D Budgets: Vericel Corporation vs Supernus Pharmaceuticals, Inc.
Comparing Innovation Spending: ImmunityBio, Inc. and Supernus Pharmaceuticals, Inc.